Banner
Soda Bans, Bike Lanes: Which 'natural Experiments' Really Reduce Obesity?

Banning sodas from school vending machines, building walking paths and playgrounds, adding supermarkets...

Shrinking Habitats Have Adverse Effects On World Ecosystems

An extensive study of global habitat fragmentation - the division of habitats into smaller and...

10 Tips For Choosing An Academic Dean

Clear and realistic expectations are key to successfully hiring heads of departments, say Professor...

Levee Detonations Reduced 2011 Flood Risk On Mississippi River

A controversial decision in 2011 to blow up Mississippi River levees reduced the risk of flooding...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll
NGC 253 is one of the brightest and dustiest spiral galaxies in the sky but we are always learning new things about it.   Astronomers using the Very Large Telescope's (VLT) near-infrared eye called NACO, an adaptive optics instrument, are now saying that the  center of NGC 253 hosts a scaled-up version of Sagittarius A*, the bright radio source that lies at the core of the Milky Way, and which we know harbors a massive black hole.

"We have thus discovered what could be a twin of our Galaxy's Centre," says co-author Almudena Prieto, part of the group of astronomers from the Instituto de Astrofísica de Canarias (Spain) and lead author of a new paper on the topic, which also disclosed a  group of new young, massive and dusty stellar nurseries there.
A review article published in the European journal Psychotherapy and Psychosomatics says there is a relationship between depression and bone metabolism.

The study says that the association between psychiatric illness, in particular depression, and osteoporosis has been the subject of a growing body of research yielding various findings, although most identify some effect on bone. In addition to medication-related processes and/or modifiable lifestyle factors associated with mood disturbances, endocrine and immune alteration secondary to depression may play a pathogenetic role in bone metabolism.
Scientists who study how human chemistry can permanently turn off genes have typically focused on small islands of DNA believed to contain most of the chemical alterations involved in those switches. But after an epic tour of so-called DNA methylation sites across the human genome in normal and cancer cells, Johns Hopkins scientists have found that the vast majority of the sites aren’t grouped in those islands at all, but on nearby regions that they’ve named “shores.” 
Even 150 years after Charles Darwin’s epochal On the Origin of Species many questions about the molecular basis of evolution are still waiting for answers.

How are signaling pathways changed by genes and by the environment enabling the development of new species?

A group of scientists at the Max Planck Institute for Developmental Biology in Tübingen, Germany, are striving to decode the molecular basis of parasitism and their objects of research are nematode worms. Do the dauer stages which occur in certain nematodes and the infective larvae of their parasitic cousins share a common evolutionary basis?

Transiting exoplanets are routinely detected when they pass in front of their parent star as viewed from the Earth, which only happens by chance. The transit event causes a small drop in the observed starlight, which can then be detected.
Smallpox has a nasty history throughout the world. Caused by poxviruses, smallpox is one of the few disease-causing agents against which the human body’s immune system is ineffective.

The human immune system is rendered helpless against poxviruses partly because the viruses block a human immune molecule, interleukin-18 (IL-18), from sending out a signal to the immune system. The body acts as if everything is fine and the deadly disease takes over.

A major breakthrough by Junpeng Deng, a structural biologist in the Division of Agricultural Sciences and Natural Resources (DASNR) at Oklahoma State University, and his first-year Ph.D. student, Brian Krumm, may be the first step towards a pharmaceutical medication for smallpox and the emerging human monkeypox.